PanGen Biotech Inc (222110) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.33x

PanGen Biotech Inc (222110) has a Cash Flow Reinvestment Rate of 0.33x as of June 2025, reinvesting ₩1.07 Billion (capex ₩56.30 Million plus investments ₩1.01 Billion) from operating cash flow of ₩3.22 Billion. Check earnings quality score of PanGen Biotech Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.33x

(Capex + Investments) / Operating CF

Total Reinvested

₩1.07 Billion

Capex + Investments

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

PanGen Biotech Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for PanGen Biotech Inc across 1 annual periods. Explore 222110 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for PanGen Biotech Inc (2024–2024)

Year-by-year capital reinvestment analysis for PanGen Biotech Inc. For live market cap and broader valuation context, see 222110 company net worth.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2024	3.59x	₩10.71 Billion	₩2.99 Billion	₩374.12 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow